- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00815997
Novel Angioplasty Using Coronary Accessor (NAUSICA)
Novel Angioplasty USIng Coronary Accessor
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Prerequisites for TRI were a sufficiently pulsating radial artery and presence of an ulnar pulse with a sufficient palmar arch, as evidenced by the absence of digital ischemia according to the Allen's test. Exclusion criteria for the current study included planned use of a cutting balloon, rotational atherectomy, directional coronary atherectomy, and intravascular ultrasound, which were not compatible with 4-Fr catheter.
Patency of the radial artery after TRI will be evaluated by pulsation of the radial artery, and frequencies of which will be compared between those receiving 4Fr vs 6 Fr coronary interventions.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
AP
-
Hyderabad, AP, India
- Global Hospital
-
Secunderabad, AP, India, 500003
- Krishna Institute of Medical Sciences
-
-
-
-
-
Aomori, Japan, 030-8553
- Aomori Prefectural Central Hospital
-
Fukuoka, Japan, 813-0036
- Fukuoka Heart Clinic
-
Kyoto, Japan, 601-8453
- Kyoto Kujo Hospital
-
-
Aichi
-
Seto, Aichi, Japan, 489-8652
- Tosei General Hospital
-
-
Chiba
-
Narashino, Chiba, Japan, 275-0006
- Chibaken Saiseikai Narashino Hospital
-
-
Fukuoka
-
Kurume, Fukuoka, Japan, 830-8577
- Shin-Koga Hospital
-
-
Hokkaido
-
Sapporo, Hokkaido, Japan, 065-0033
- Sapporo Higashi Tokushukai Hospital
-
Sapporo, Hokkaido, Japan, 007-8505
- Kin-ikyo Central Hospital
-
-
Hyogo
-
Kobe, Hyogo, Japan, 654-0026
- Sakurakai Takahashi Hospital
-
Nishinomiya, Hyogo, Japan, 665-8501
- Hyogo College of Medicine
-
-
Kanagawa
-
Atsugi, Kanagawa, Japan, 243-8551
- Shonan Atsugi Hospital
-
Isehara, Kanagawa, Japan, 259-1193
- Tokai University
-
Kamakura, Kanagawa, Japan, 247-8533
- Shonan Kamakura General Hospital
-
Yokohama, Kanagawa, Japan, 232-0024
- Yokohama City University Medical Center
-
-
Kumamoto
-
Yatsushiro, Kumamoto, Japan, 866-8533
- Kumamoto Rosai Hospital
-
-
Tochigi
-
Shimotsuke, Tochigi, Japan, 329-0498
- Jichi Medical University
-
-
-
-
Pai-Tou
-
Taipei, Pai-Tou, Taiwan, 112
- Cheng Hsin General Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Prerequisites for transradial intervention were a sufficiently pulsating radial artery and presence of an ulnar pulse with a sufficient palmar arch, as evidenced by the absence of digital ischemia according to the Allen's test.
Exclusion Criteria:
- Exclusion criteria included planned use of a cutting balloon, rotational atherectomy, directional coronary atherectomy, and intravascular ultrasound, which were not compatible with 4-Fr catheter.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Sham Comparator: 6-Fr TRI (transradial coronary intervention)
TRI will be performed using a 6-Fr guiding catheter.
|
PCI will be performed via the radial artery.
|
|
Active Comparator: 4-Fr TRI
TRI will be performed using a 4-Fr guiding catheter.
|
PCI will be performed via the radial artery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Patients With Radial Artery Occlusion
Time Frame: within 2 days after TRI
|
The primary endpoint was radial artery occlusion the day after TRI, defined as the absence of a radial pulse confirmed by a reverse Allen's test.
|
within 2 days after TRI
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Patients With Successful PCI
Time Frame: within 2 days after TRI
|
Procedural success was defined as a postprocedural residual stenosis of less than 20%, and a thrombolysis in myocardial infarction (TIMI) grade 3 angiographic flow without MACE during in-hospital follow-up.
|
within 2 days after TRI
|
|
Number of Patients With Measure Adverse Cardiac Event (MACE)
Time Frame: within 2 days after TRI
|
Defined as a composite of cardiac death, myocardial infarction, and target lesion revascularization
|
within 2 days after TRI
|
|
Number of Patients With Access-site Complications
Time Frame: within 2 days after TRI
|
Access-site-related complications were defined as bleeding, pseudoaneurysm, arteriovenous fistula, and occlusion of the radial artery, which were considered to be major if they were associated with a vascular repair or a blood transfusion.
|
within 2 days after TRI
|
|
Fluoroscopy Time Used for the Procedure
Time Frame: At the end of TRI
|
Fluoroscopy time used for the procedure (minutes).
|
At the end of TRI
|
|
Contrast Dye Volume Used for the Procedure
Time Frame: At the end of TRI
|
Contrast dye volume used for the procedure (mL).
|
At the end of TRI
|
|
Time Used for the Procedure
Time Frame: At the end of TRI
|
Time used for the procedure (minutes).
|
At the end of TRI
|
|
Time Used for Hemostasis
Time Frame: within 2 days afterTRI
|
Time Used for Hemostasis (minutes).
|
within 2 days afterTRI
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Shigeru Saito, MD, Vice Preseident, Shonan Kamakura General Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2008-28
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patency of the Radial Artery
-
Instituto de Cardiologia de Santa CatarinaCompletedInjury of Radial ArteryBrazil
-
Sheba Medical CenterWithdrawn
-
Oslo University HospitalHelse Sor-OstCompletedHemostasis | Injury of Radial Artery | Peripheral Artery OcclusionNorway
-
Total Cardiovascular SolutionsUnknownTotal Atherosclerotic Occlusion of Radial ArteryIndia
-
University of British ColumbiaCompletedTime to Insertion of Radial Artery CannulationCanada
-
Kliniken Ludwigsburg-Bietigheim gGmbHKlinikum Ludwigshafen; Universitätsmedizin MannheimUnknownTo Evaluate Patency of the Viaduct Stent in Comparison to Metal StentsGermany
-
Hermina Heart Center KemayoranHermina Hospital GroupCompletedVasodilation | Radial Artery Injury at Wrist and Hand Level | Occlusion of ArteryIndonesia
-
Azienda Sanitaria ULSS 13 Dolo, MiranoUnknownEmbolism and Thrombosis of the Radial ArteryItaly
-
Biomet Orthopedics, LLCTerminatedDegenerative Conditions of the Radial Head/Neck | Post-traumatic Conditions of the Radial Head/NeckUnited States
-
University Hospital of PatrasRecruitingDistal Radial Artery Access (dTRA) | Radial Artery AccessGreece
Clinical Trials on PCI (percutaneous coronary intervention)
-
Herlev and Gentofte HospitalUnknownCoronary Heart Disease | Ischemic Heart Disease | Stable AnginaDenmark
-
Philips Clinical & Medical Affairs GlobalCompletedCoronary Artery DiseaseIsrael, United States, Belgium, Spain
-
Assiut UniversityNot yet recruiting
-
Xijing HospitalUnknown
-
Vastra Gotaland RegionKarolinska University Hospital; University Hospital, Umeå; Region Örebro CountyRecruiting
-
Imperial College LondonMid and South Essex NHS Foundation Trust; Imperial College Healthcare NHS TrustCompletedCoronary Artery Disease | Angina, StableUnited Kingdom
-
Helse Stavanger HFHelse Vest; Norwegian Foundation for Health and Rehabilitation; Amersham Health; Norwegian Heart and Lung Patient Organization and other collaboratorsCompleted
-
Aarhus University Hospital SkejbyTerumo Europe N.V.; Johnson & JohnsonCompletedCoronary Artery Disease | Angina PectorisDenmark
-
Vastra Gotaland RegionYale University; Hannover Medical School; University of Copenhagen; Weill Medical... and other collaboratorsRecruiting
-
University of British ColumbiaRecruitingCoronary Artery Disease | Aortic Stenosis | Coronary StenosisCanada, United States